<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00874458</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000633336</org_study_id>
    <secondary_id>CALACASS-CCIS</secondary_id>
    <secondary_id>CALACASS-2006/25</secondary_id>
    <secondary_id>CALACASS-ID-RCB-2006-A00251-50</secondary_id>
    <secondary_id>INCA-RECF0620</secondary_id>
    <nct_id>NCT00874458</nct_id>
  </id_info>
  <brief_title>MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ</brief_title>
  <official_title>Ductal Carcinoma in Situ: Protocol Evaluating the Assessment of Extension of Disease by MRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Antoine Lacassagne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Antoine Lacassagne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Diagnostic procedures, such as MRI, may help find ductal carcinoma in situ and
      find out how far the disease has spread.

      PURPOSE: This clinical trial is studying how well MRI works in assessing tumor size in women
      with ductal carcinoma in situ.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

      Primary

        -  Assess the contribution of MRI in accurately determining tumor size in women with ductal
           breast carcinoma in situ (DCIS).

      Secondary

        -  Evaluate the sensitivity of MRI in detecting DCIS.

        -  Evaluate the contribution of mammography in accurately determining tumor size.

        -  Compare the contribution of MRI vs mammography in assessing tumor extension.

        -  Compare the contribution of MRI vs mammography in assessing dense breasts.

        -  Evaluate the morphology of DCIS by MRI.

        -  Evaluate the curve of dynamic MRI in assessing DCIS.

        -  Evaluate the impact of nuclear grade of DCIS by MRI.

        -  Evaluate the rate of revision surgery.

      OUTLINE: Patients undergo clinical examination, mammography, ultrasound imaging, unilateral
      breast MRI, and tissue sampling.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of tumor extension by MRI with surgical histology</measure>
    <time_frame>up to 1 year</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>magnetic resonance imaging</intervention_name>
    <arm_group_label>MRI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>radiomammography</intervention_name>
    <arm_group_label>MRI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ultrasound imaging</intervention_name>
    <arm_group_label>MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Diagnosis of ductal breast carcinoma in situ

               -  Any grade disease allowed

          -  Unifocal disease by mammography

          -  No history of breast cancer

          -  Hormone receptor status not specified

        PATIENT CHARACTERISTICS:

          -  Menopausal status not specified

          -  WHO performance status 0-2

          -  Glomerular filtration rate â‰¥ 30 mL/min

          -  Not pregnant or nursing

          -  Fertile patients must use effective contraception

          -  No allergy or contraindication to contrast MRI

          -  No pacemaker or vascular clip

        PRIOR CONCURRENT THERAPY:

          -  No prior or concurrent liver transplantation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire Chapellier</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Antoine Lacassagne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Antoine Lacassagne</name>
      <address>
        <city>Nice</city>
        <zip>06189</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2009</study_first_submitted>
  <study_first_submitted_qc>April 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2009</study_first_posted>
  <last_update_submitted>November 20, 2014</last_update_submitted>
  <last_update_submitted_qc>November 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ductal breast carcinoma in situ</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma in Situ</mesh_term>
    <mesh_term>Carcinoma, Ductal</mesh_term>
    <mesh_term>Carcinoma, Intraductal, Noninfiltrating</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

